Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial.

Hdl Handle:
http://hdl.handle.net/10147/559165
Title:
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial.
Authors:
Mone, F; McAuliffe, F M
Citation:
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial. 2015, 108 (1):5 Ir Med J
Publisher:
Irish Medical Journal
Journal:
Irish medical journal
Issue Date:
Jan-2015
URI:
http://hdl.handle.net/10147/559165
PubMed ID:
25702343
Abstract:
Obstetric practice is evolving; the future will see a shift in the focus of care to the pre-conceptual period and early trimester with a move towards interventions which optimize maternal and neonatal outcome. 1 Low dose Aspirin (LDA) is one such intervention. The safety and efficacy of this medicinal product has already been proven 2,3 and subsequently it is now used common in practice for at-risk pregnancies for prevention of pre-eclampsia, fetal growth restriction and complications of anti-phospholipid syndrome.
Item Type:
Article
Language:
en
Keywords:
PREGNANCY; MEDICINES; PRE-ECLAMPSIA
MeSH:
Abortion, Spontaneous; Aspirin; Birth Rate; Female; Humans; Ireland; Live Birth; Pre-Eclampsia; Pregnancy; Prenatal Care; Randomized Controlled Trials as Topic
ISSN:
0332-3102

Full metadata record

DC FieldValue Language
dc.contributor.authorMone, Fen
dc.contributor.authorMcAuliffe, F Men
dc.date.accessioned2015-07-07T14:41:36Zen
dc.date.available2015-07-07T14:41:36Zen
dc.date.issued2015-01en
dc.identifier.citationPreconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial. 2015, 108 (1):5 Ir Med Jen
dc.identifier.issn0332-3102en
dc.identifier.pmid25702343en
dc.identifier.urihttp://hdl.handle.net/10147/559165en
dc.description.abstractObstetric practice is evolving; the future will see a shift in the focus of care to the pre-conceptual period and early trimester with a move towards interventions which optimize maternal and neonatal outcome. 1 Low dose Aspirin (LDA) is one such intervention. The safety and efficacy of this medicinal product has already been proven 2,3 and subsequently it is now used common in practice for at-risk pregnancies for prevention of pre-eclampsia, fetal growth restriction and complications of anti-phospholipid syndrome.en
dc.language.isoenen
dc.publisherIrish Medical Journalen
dc.rightsArchived with thanks to Irish medical journalen
dc.subjectPREGNANCYen
dc.subjectMEDICINESen
dc.subjectPRE-ECLAMPSIAen
dc.subject.meshAbortion, Spontaneousen
dc.subject.meshAspirinen
dc.subject.meshBirth Rateen
dc.subject.meshFemaleen
dc.subject.meshHumansen
dc.subject.meshIrelanden
dc.subject.meshLive Birthen
dc.subject.meshPre-Eclampsiaen
dc.subject.meshPregnancyen
dc.subject.meshPrenatal Careen
dc.subject.meshRandomized Controlled Trials as Topicen
dc.titlePreconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial.en
dc.typeArticleen
dc.identifier.journalIrish medical journalen
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.